The current valuation score of Cardiol Therapeutics Inc is 6.50, ranking 328 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.80, which is -66.03% below the recent high of -1.29 and -128.65% above the recent low of -8.70.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.